Published in

American Society for Cell Biology, Molecular Biology of the Cell, 11(24), p. 1638-1648

DOI: 10.1091/mbc.e12-12-0891

Links

Tools

Export citation

Search in Google Scholar

Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA–mRNA interactions

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs involved in posttranscriptional regulation of protein-coding genes in various biological processes. In our preliminary miRNA microarray analysis, miR-375 was identified as the most underexpressed in human oral tumor versus controls. The purpose of this study was to examine the function of miR-375 as a candidate tumor suppressor miRNA in oral cancer. Cancerous inhibitor of PP2A (CIP2A), a guardian of oncoprotein MYC, was identified as a candidate miR-375 target based on bioinformatics. Luciferase assay accompanied with target sequence mutagenesis elucidated five functional miR-375 binding sites clustered in the CIP2A coding sequence close to the C-terminal domain. Overexpression of CIP2A was clearly demonstrated in oral cancers and inverse correlation between miR-375 and CIP2A was observed in the tumors as well as NCI-60 cell lines indicating the potential generalized involvement of the miR-375-CIP2A relationship in many other cancers. Transient transfection of miR-375 in oral cancer cells reduced the expression of CIP2A resulting in decrease of MYC protein levels, leading to reduced proliferation, colony formation, migration, and invasion. Therefore, this study demonstrated that underexpression of a tumor suppressor miR-375 could lead to uncontrolled CIP2A expression and extended the stability of MYC, which contributes to promoting cancerous phenotypes.